Consumer watchdog asks FDA to revisit compounders

(AP)—A government watchdog group is calling on the Food and Drug Administration to re-inspect more than a dozen specialty pharmacies with prior records of violations, in light of a recent deadly outbreak tied to compounded drugs.

Contaminated pain injections from a Massachusetts compounding pharmacy have been blamed for that has killed 36 people and sickened more than 500, according to .

In a letter to the FDA sent Thursday, Public Citizen asks the agency to revisit 16 compounding pharmacies that received warning letters from the agency between 2003 and 2009.

Compounding pharmacies traditionally mix customized medications based on doctors' instructions, turning out a small number of specialized products for patients with unusual medical needs. However, some pharmacies have grown into much larger businesses in recent years.


Explore further

Senate questions pharmacy boards after outbreak

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: Consumer watchdog asks FDA to revisit compounders (2012, November 29) retrieved 23 August 2019 from https://medicalxpress.com/news/2012-11-consumer-watchdog-fda-revisit-compounders.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more